| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
BioNTech (NASDAQ:BNTX) is preparing to release its quarterly earnings on Monday, 2025-11-03. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect BioNTech to report an earnings per share (EPS) of $0.75.
Investors in BioNTech are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
The company's EPS missed by $0.51 in the last quarter, leading to a 0.95% increase in the share price on the following day.
Here's a look at BioNTech's past performance and the resulting price change:
| Quarter | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| EPS Estimate | -1.31 | -2.35 | 0.37 | -1.67 |
| EPS Actual | -1.82 | -1.82 | 1.15 | 0.89 |
| Price Change % | 1.00 | -6.00 | -7.00 | 2.00 |
Shares of BioNTech were trading at $104.67 as of October 30. Over the last 52-week period, shares are down 4.38%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.
To track all earnings releases for BioNTech visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: BNTX
